Connect with us

Health

Singapore blocks GenderGP website over licensing issues and public health risk concerns

Authorities have blocked access to GenderGP, citing public health risks. Founded by Dr Helen Webberley in 2015, the teleconsultation platform offers hormone therapy and puberty blockers. While registered in Singapore, it is not a licensed healthcare provider, and its doctors lack local registration, said MOH and IMDA.

Published

on

SINGAPORE: Authorities have restricted access to the website of online gender clinic GenderGP, citing public health risk concerns and alleged regulatory breaches.

GenderGP, a teleconsultation platform established in 2015 by English physician Dr Helen Webberley, provides services such as hormone therapy and puberty blockers.

Although GenderGP is a registered entity in Singapore, it is not licensed under the Healthcare Services Act 2020, according to a joint statement from the Ministry of Health (MOH) and the Infocomm Media Development Authority (IMDA) reported by CNA.

An archived version of GenderGP’s official website states that the platform is owned by Singapore-based GenderGP PTE Ltd, a global organisation offering advocacy services for LGBTQI+ individuals worldwide.

Safety concerns and licensing issues

Authorities confirmed on 4 December 2024 that GenderGP’s prescriptions and services are not recognised locally.

“There is no assurance that GenderGP’s services are safe or effective. ” the statement said.

MOH noted that the clinic’s doctors are not registered medical practitioners in Singapore.

The platform came under scrutiny after MOH found that its foreign-based doctors conducted teleconsultations and issued a prescription to a user in Singapore.

MOH issued a warning to GenderGP on 22 October, demanding a halt to its services for Singapore-based clients.

Authorities stated, “GenderGP has been warned not to re-offend,” and violations could result in fines of up to S$100,000 (US$74,000), imprisonment of up to two years, or both. Harsher penalties apply to repeat offences.

IMDA subsequently acted to block access to GenderGP’s website, citing public health risks.

Visitors to the site are now met with a pop-up message indicating that the clinic’s services are unavailable in Singapore.

Controversies surrounding GenderGP

GenderGP has faced significant controversy in the United Kingdom.

In 2017, Dr Webberley was temporarily suspended by the UK’s General Medical Council (GMC) following complaints about her clinical practices.

In 2018, she was convicted of operating an unregistered medical agency. Although her suspension was overturned in 2023, her licence was revoked in July 2024 for failing to comply with revalidation requirements.

The clinic has also been accused of prescribing sex change medications to minors without parental consent.

Investigations by The Telegraph in 2021 and BBC in 2023 highlighted cases where minors were prescribed high levels of hormones without adequate medical oversight.

These incidents were raised in the UK Parliament by Scottish politician Neale Hanvey.

Singapore’s medical registration requirements

Authorities emphasised that Dr Webberley is not licensed to practise in Singapore.

Foreign doctors seeking registration in Singapore must provide a Certificate of Good Standing from their professional authority and disclose any disciplinary actions.

MOH and IMDA warned against using GenderGP’s services, stressing that telehealth services without prior medical evaluations or clinical assessments are unsafe.

“It is clinically unsafe and inappropriate for persons in Singapore to seek telehealth services from GenderGP without any prior medical examination, clinical evaluation, or blood tests,” the joint statement noted.

Click to comment
Subscribe
Notify of
0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

Trending